Sodium Iodide → HCID 11526363, compound
Reaction equation
NS(N)(=O)=O.Cl[CH2:7][CH2:8][CH2:9][S:10]([N:13]1[CH2:18][CH2:17][CH:16]([C:19]2[C:27]3[C:22](=[C:23]([C:35]([NH2:37])=[O:36])[CH:24]=[C:25]([C:28]4[CH:33]=[CH:32][C:31]([F:34])=[CH:30][CH:29]=4)[CH:26]=3)[NH:21][CH:20]=2)[CH2:15][CH2:14]1)(=[O:12])=[O:11].[NH:38]1[CH2:42][CH2:41][CH2:40][CH2:39]1.C([O-])([O-])=O.[K+].[K+].[Na+].[I-]>>[F:34][C:31]1[CH:32]=[CH:33][C:28]([C:25]2[CH:26]=[C:27]3[C:22](=[C:23]([C:35]([NH2:37])=[O:36])[CH:24]=2)[NH:21][CH:20]=[C:19]3[CH:16]2[CH2:17][CH2:18][N:13]([S:10]([CH2:9][CH2:8][CH2:7][N:38]3[CH2:42][CH2:41][CH2:40][CH2:39]3)(=[O:12])=[O:11])[CH2:14][CH2:15]2)=[CH:29][CH:30]=1Participants
6
Procedure
Following the general procedure for aminosulfonamide formation outlined in example 2, 3-{1-[(3-chloropropyl)sulfonyl]-4-piperidinyl}-5-(4-fluorophenyl)-1H-indole-7-carboxamide (0.059 mmol) and pyrrolidine (0.025 mL, 0.295 mmol) were allowed to react in the presence of K2CO3 (37 mg, 0.118 mmol) and NaI (Cat. 2 mg). The resulting residue was purified by reverse phase HPLC eluting with 10% B to 80% B, where A=H2O (0.1% trifluoroacetic acid) and B=CH3CN (0.1% trifluoroacetic acid) to give the title compound (6.9 mg, 23%).
Workup
- customThe resulting residue was purified by reverse phase HPLC
- washeluting with 10% B to 80% B, where A=H2O (0.1% trifluoroacetic acid) and B=CH3CN (0.1% trifluoroacetic acid)
Sources & evidence
- ORD record
- ord-1a81e51268b6460880965fbe2c5fcaf0
- Source dataset
- uspto-grants-2010_12
- Patent number
- US07858796B2
Reaction notes
Loading…